MAI Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
87
+78
| +867% | +$17.1K | ﹤0.01% | 2225 |
|
|
2025
Q1 | $2.02K | Sell |
9
-140
| -94% | -$31.3K | ﹤0.01% | 2797 |
|
|
2024
Q4 | $48.8K | Buy |
+149
| New | +$48.8K | ﹤0.01% | 1677 |
|
|
2022
Q3 | – | Sell |
-3,159
| Closed | -$955K | – | 1000 |
|
|
2022
Q2 | $955K | Sell |
3,159
-3
| -0.1% | -$907 | 0.02% | 373 |
|
|
2022
Q1 | $1.3M | Sell |
3,162
-231
| -7% | -$94.9K | 0.02% | 331 |
|
|
2021
Q4 | $1.59M | Buy |
3,393
+6
| +0.2% | +$2.81K | 0.03% | 316 |
|
|
2021
Q3 | $1.44M | Buy |
3,387
+2
| +0.1% | +$849 | 0.03% | 296 |
|
|
2021
Q2 | $1.22M | Sell |
3,385
-15
| -0.4% | -$5.39K | 0.02% | 314 |
|
|
2021
Q1 | $958K | Buy |
3,400
+19
| +0.6% | +$5.35K | 0.02% | 332 |
|
|
2020
Q4 | $958K | Sell |
3,381
-134
| -4% | -$38K | 0.02% | 313 |
|
|
2020
Q3 | $966K | Sell |
3,515
-905
| -20% | -$249K | 0.03% | 273 |
|
|
2020
Q2 | $1M | Buy |
+4,420
| New | +$1M | 0.03% | 260 |
|